Cadisegliatin (CAS Number: 859525-02-3)
A Comprehensive Overview Introduction A pharmaceutical compound, Cadisegliatin (CAS 859525-02-3) being developed for treatment of type 2 diabetes mellitus (T2DM) in research and development. Scientific and medical interest in Cadisegliatin has been drawn by its unique mechanism of action with potential to address unmet needs in diabetes management. This article addresses the compound’ mechanism of […]
Bomedemstat (CAS: 1990504-72-7) :
Bomedemstat: A Revolutionary Approach in Hematological Malignancies Introduction Discovery and development of targeted therapies are revolutionizing the field of hematology. One of these breakthroughs is a small molecule LSD1 inhibitor: **Bomedemstat**. **Inhibition of LSD1 has shown promise as new therapeutic paradigms for hematological malignancies, with a focus on myeloproliferative neoplasms (MPNs)** and other blood disorders. […]
Aprocitentan (CAS 1103522-45-7)
Treatment of Hypertension and Cardiovascular Disorders: A BreakthroughCAS number 1103522-45-7 a novel dual endothelin receptor antagonist (ERA) Aprocitentan is an innovative dual ERA that has recently taken the medical world by storm.3522-45-7 , is an innovative dual endothelin receptor antagonist (ERA) that has garnered significant attention in the medical community. Aprocitentan could become a breakthrough […]
Abivertinib (CAS: 1557267-42-1):
A Comprehensive Overview Introduction : The novel, third generation tyrosine kinase inhibitor (TKI) abivertinib (CAS Number: 1557267-42-1) has high affinity for EGFR (epidermal growth factor receptor) mutations. It is an oral small molecule inhibitor developed to overcome resistance mechanisms associated with previous generations of EGFR inhibitors. Abivertinib has large potential as an oncology and immunology […]
Epoprostenol Sodium (CAS: 61849-14-7):
An Introduction The CAS number of this pharmaceutical compound is 61849-14-7 and it is an epoprostenol sodium, an analogue of prostacyclin. It’s a potent vasodilator, and inhibitor of platelet aggregation derived from arachidonic acid. Because this drug has a unique mechanism of action, it is primarily used in the treatment of PAH (and other vascular […]
Understanding Ursodoxicoltaurine+combo (AMX-0035): Potential in Treating Neurodegenerative Diseases
Ursodoxicoltaurine+combo (AMX-0035), identified by its chemical number 14605-22-2, has been making headlines as a promising drug combination in the fight against neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease. This compound, which combines ursodoxicoltaurine with other active agents, holds the potential to address critical pathways involved in these debilitating conditions. Let’s explore its […]
Inavolisib (RG-6114, RO-7113755): A Comprehensive Overview
Introduction As a novel drug compound, also called research codes RG-6114 and RO-7113755, Inavolisib is recognized for its therapeutic potential, particularly in oncology. This compound, with chemical identifier CAS number 2060571-02-8, is under study as a therapeutic target for specific cancers. This article investigates research based on Invisible review, including the molecular mechanisms, clinical relevance, […]
Givinostat (ITF-2357): A Comprehensive Overview
Introduction The compound ITF-2357, also known as givinostat, is a potent, selective HDACi with established anti-inflammatory and anti-cancer properties. CAS number 497833-27-9 and extensively studied for its therapeutic applications in the oncology, hematology, and rare disease spaces. The mechanisms of action, pharmacological profile, clinical applications and future prospects of Givinostat are studied in this article. […]
GSK-2140944, or gepotidacin
GlaxoSmithKline (GSK) is developing a new type of antibiotic . Unlike existing antibiotics, it operates differently, and represents a promising approach to treating bacteria that have become resistant to current treatments. How Gepotidacin Works Gepotidacin targets two essential bacterial enzymes: Topoisomerase IV and DNA gyrase. They also help bacteria get their DNA organized when they […]
Gepirone
Chemical identifier CAS number 83928-76-1, is primarily used as a medication to treat major depressive disorder (MDD). It is an azapirone drug, as other drugs in this class act upon the brain’s serotonin receptors. Gepirone is a selective partial agonist at the 5HT_1A receptor, in that it activates this receptor but not fully. This is […]
English 
Chinese